Chie Tanaka - Publications

Robotic Transperineal Lateral Lymph Node Dissection for Rectal Cancer Through a Single-Port System: the World's First Clinical Experience.

Journal: Diseases of the colon and rectum

Published: September 03, 2026

Clinical practice guidelines for duodenal cancer 2025.

Journal: Journal of gastroenterology

Published: July 31, 2026

ASO Visual Abstract: High Serum IgA Identifies Poor Responders to Immune Checkpoint Inhibitors in Patients with Unresectable Esophageal Squamous Cell Carcinoma.

Journal: Annals of surgical oncology

Published: June 15, 2026

Analysis of Formimidoyltransferase Cyclodeaminase as a Potential Prognostic Biomarker and Therapeutic Target in Colorectal Cancer.

Journal: Cancer genomics & proteomics

Published: May 01, 2026

Sex differences in operative opportunities with early adoption of robot-assisted surgery.

Journal: Surgery

Published: April 06, 2026

BBS5 as a robust prognostic biomarker in esophageal squamous cell carcinoma: validation in two independent cohorts.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 18, 2026

High Serum IgA Identifies Poor Responders to Immune Checkpoint Inhibitors in Patients with Unresectable Esophageal Squamous Cell Carcinoma.

Journal: Annals of surgical oncology

Published: January 16, 2026

Six key elements for effective coordination in home-based care for older adults with cancer in Japan: A qualitative interview study.

Journal: Journal of geriatric oncology

Published: December 29, 2025

An analysis of mechanism and site of injury associated with emergency procedures and mortality using a Japanese nationwide trauma registry.

Journal: Injury

Published: November 28, 2025

Comparison of Clinical Outcomes, Diagnosis Timing, or Treatment Differences Based on Motor Subtypes of Delirium in Critically Ill Patients: A Retrospective Study.

Journal: Psychiatry and clinical psychopharmacology

Published: November 17, 2025

Phase II study of FOLFIRI with low-dose irinotecan plus ramucirumab as second-line treatment in Japanese patients with metastatic colorectal cancer (study rindo).

Journal: Japanese journal of clinical oncology

Published: September 05, 2025

Annual Report of the 2022 National Clinical Database: Decade-Long Trends and Current Status of Gastroenterological Surgery in Japan.

Journal: Annals of gastroenterological surgery

Published: July 16, 2025